Highlights Centogene N.V.

Equities

CNTG

NL0014040206

Delayed Nasdaq Other stock markets 01:24:31 2024-05-14 pm EDT			5-day change	1st Jan Change
0.438 ^USD	+9.53%		-2.67%	-63.50%

05:06pm	Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment	MT
May. 10	Centogene Biodatabank Grows to Incorporate Disease Insights from over 850,000 Diverse Patients	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment	11:06am	MT
Centogene Biodatabank Grows to Incorporate Disease Insights from over 850,000 Diverse Patients	May. 10	CI
Centogene Gets Nasdaq Noncompliance Notice	Apr. 02	MT
Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics	Mar. 19	MT
Centogene N.V. Announces the Extension of an Ongoing Partnership with Takeda to Continue Providing Access to Genetic Testing for Patients with Lysosomal Storage Disorders	Mar. 19	CI
Centogene N.V. and the Laboratory of Human Genetics of Infectious Diseases At Institut Imagine Announce Rare Disease Research Collaboration	Jan. 25	CI
Centogene N.V. and The Michael J. Fox Foundation for Parkinson's Research Announces Research Project to Validate Genetic Risk Factors of Parkinson's Disease Using Multiomics	Jan. 23	CI
Centogene N.V. Provides Earnings Guidance for the Full Year 2023	Jan. 18	CI
Centogene N.V.'s Frontotemporal Dementia Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone	Dec. 13	CI
Centogene, Saudi Arabia's Public Investment Fund Form JV	Nov. 28	MT
Centogene N.V. and Lifera Complete Strategic Joint Venture Transaction	Nov. 28	CI
Centogene N.V. Announces the Discovery of A New Form of Early-Onset Dystonia and Parkinsonism	Nov. 14	CI
Centogene N.V. Expands Multiomic Diagnostic Portfolio with Newly-Launched Transcriptomic Offering	23-10-10	CI
Centogene N.V. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-07	CI
Centogene N.V. Reaffirms Revenue Guidance for the Year 2023	23-09-07	CI
Upcoming Payrolls Report Lifts Exchange-Traded Funds, Equity Futures Premarket Friday	23-09-01	MT
Centogene N.V. Announces Publication Establishing Lyso-Gb1 as A Predictive Biomarker for Gaucher Disease Patients	23-09-01	CI
Centogene Receives Non-Compliance Notice From Nasdaq	23-09-01	MT
Centogene Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohort	23-07-12	CI
Centogene Teams Up With Lifera to Boost Access to Multiomic Testing in Saudi Arabia	23-07-03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Centogene N.V.

Equities

CNTG

NL0014040206

Highlights

Filters